Navigation Links
Heart Hospital of Austin First in World to Use New Device for Blocked Arteries
Date:1/8/2009

New magnetically-navigated guidewire provides minimally-invasive treatment for Peripheral Artery Disease

AUSTIN, Texas, Jan. 8 /PRNewswire/ -- The Heart Hospital of Austin is the first hospital in the world to use the new Stereotaxis RF PowerAssert(TM) Magnetic Guidewire to successfully treat chronic total occlusions (CTOs), or complete blockages in patients with peripheral artery disease.

Austin Heart interventional cardiologist, Frank Zidar, M.D. used the new device on Wednesday, January 7, 2009, on a patient with severe peripheral artery disease (PAD). The patient had 100% blockage in a main artery in his leg. Without proper treatment, he would continue to experience chronic, severe pain in his leg due to poor circulation, according to a hospital spokesperson.

"Traditional treatment for blocked arteries uses manual guidewires to travel through the artery to the area of blockage in the leg. This can be extremely challenging because these guidewires are very difficult to maneuver. This new magnetic guidewire technology allows for greater control and improved accuracy," explains Dr. Frank Zidar.

"Once the blockage is reached, the tip of the guidewire can burn or ablate a tiny passage through the blockage, allowing us then to use existing techniques to open up the blockage further. This revolutionary technology will likely reduce procedure times and therefore reduce the amount of contrast dye and imaging radiation to the patient," he added.

Peripheral Artery Disease affects eight to twelve million Americans, according to the American Heart Association. If left untreated, patients can experience ulcerations and gangrene that significantly increase their risk of losing a limb or even result in death.

The Stereotaxis RF PowerAssert(TM) Magnetic Guidewire was approved by the FDA in August 2008. It is the only magnetically enabled device capable of intra-lesion steering available for crossing completely blocked arteries.

Heart Hospital of Austin was chosen as one of only two clinical sites in the world to study the efficacy of the new Stereotaxis RF PowerAssert(TM) Magnetic Guidewire.


'/>"/>
SOURCE Heart Hospital of Austin
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD
2. Mortality rates higher for heart disease patients in poorer B.C. neighborhoods
3. CVBT Opens Two Additional Sites for Its ACORD Phase II Heart Trial
4. Heart Drug May Be a Cancer Fighter
5. Traditional risk assessment tools do not accurately predict coronary heart disease
6. New SMHEART LINK(TM) Technology Allows iPhones to Double as Fitness Monitors
7. Randy Jackson and the American Heart Association Encourage Philadelphia Residents to Get In The K.N.O.W. About Improving Type 2 Diabetes Management
8. New appropriate use criteria guide treatment of patients with heart blockage
9. Viagra May Shield Heart From Blood Pressure Damage
10. New hope for cancer comes straight from the heart
11. When the Heart Stops Beating
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... ... further expand its existing adherence automation lines. The ATP® Mini and InspectRx® ... technology of TCG’s standard products, but at a size and price point that ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... since 2014, top travel insurance solution company VisitorsCoverage Inc. has launched TMQuotes, a ... major international travel insurance products online, under their own brand. The online marketplace ...
(Date:7/20/2017)... ... 2017 , ... A local summer theatre camp is celebrating ... support fine arts programs in Chester County’s Elementary Schools. In late June, students ... , More than 850 people attended the two performances, an increase from ...
(Date:7/20/2017)... (PRWEB) , ... July 19, 2017 , ... Med Tech ... the Minnesota based Health IT business unit of Constellation Inc., a move that will ... established base of operations in St. Louis, the acquisition is expected to help ...
(Date:7/20/2017)... ... July 19, 2017 , ... A July 5th ... weight loss surgery patients who had received a body contouring procedure reported experiencing a ... clinic Beverly Hills Physicians (BHP), which provides both types of procedures, notes that this ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... July 13, 2017  Centurion Medical Products, a leader in medical ... ® fecal impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are ... help alleviate patient pain while preventing unneeded emergency department admission due ...
(Date:7/12/2017)... Lilly and Company (NYSE: LLY ) has entered ... patent litigation in the U.S. District Court for the Eastern ... ® (tadalafil) unit dose patent. This patent was previously ... the agreement, Cialis exclusivity is now expected to end at ... dose patent for Cialis is valid and infringed by companies ...
(Date:7/11/2017)... July 11, 2017  Sysmex America, Inc., a ... testing equipment as well as middleware information systems ... to make quality assurance easier and more risk ... well known for the innovation that it delivers ... elevates quality assurance processes to a new level ...
Breaking Medicine Technology: